thimerosal

Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines Is Safe

Biomed Res Int. 2014; 2014: 247218.
Published online 2014 Jun 4. doi:  10.1155/2014/247218
PMCID: PMC4065774

Brian Hooker, 1 ,* Janet Kern, 2 , 3 David Geier, 2 Boyd Haley, 4 Lisa Sykes, 5 Paul King, 5 and Mark Geier 2
Author information ► Article notes ► Copyright and License information ►
This article has been cited by other articles in PMC.

Gender-selective toxicity of thimerosal.

Exp Toxicol Pathol. 2009 Mar;61(2):133-6. doi: 10.1016/j.etp.2008.07.002. Epub 2008 Sep 3.
Branch DR1.
Author information
1Departments of Medicine and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada. don.branch@utoronto.ca

A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.

Transl Neurodegener. 2013 Dec 19;2(1):25. doi: 10.1186/2047-9158-2-25.

Transcriptomic analyses of neurotoxic effects in mouse brain after intermittent neonatal administration of thimerosal.

Toxicol Sci. 2014 Jun;139(2):452-65. doi: 10.1093/toxsci/kfu049. Epub 2014 Mar 27.

Cultured lymphocytes from autistic children and non-autistic siblings up-regulate heat shock protein RNA in response to thimerosal challenge.

A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders.

J Matern Fetal Neonatal Med. 2007 May;20(5):385-90.

Geier DA1, Geier MR.
Author information
1The Institute of Chronic Illnesses, Silver Spring, MD, USA.

Subscribe to RSS - thimerosal